Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page revision tag advanced from v3.5.3 to v3.5.4, signaling a minor update to the study record display and related metadata.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThis updates the ClinicalTrials.gov page’s displayed revision/version number from v3.5.2 to v3.5.3, without changing any of the study details.SummaryDifference0.1%

- Check43 days agoChange DetectedA new publication reference was added to Publications, and the page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check107 days agoChange DetectedFooter revision label updated to v3.4.2 (from v3.4.1) on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check114 days agoChange DetectedThe page shows a revision label updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.